• 1
    Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 22472250.
  • 2
    Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21: 437451.
  • 3
    Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21: 311335.
  • 4
    Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000; 279: G245G249.
  • 5
    Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685698.
  • 6
    Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538549.
  • 7
    Wright MC, Issa R, Primrose JN, Arthur MJP, Iredale JP, Mann DA. Gliotoxin stimulates the apoptosis of rat and human hepatic stellate cells in vitro. In: WisseE, KnookDL, FraserR, eds. Cells of the Hepatic Sinusoid. Volume 8. Leiden, The Netherlands: Kupffer Cell Foundation, 2001: 287290.
  • 8
    Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001; 48: 548557.
  • 9
    Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R. Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci 2003; 48: 16421647.
  • 10
    Perkins ND. The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci 2000; 25: 434440.
  • 11
    Freedman AR, Sharma RJ, Nabel GJ, Emerson SG, Griffin GE. Cellular distribution of nuclear factor kappa B binding activity in rat liver. Biochem J 1992; 287: 645649.
  • 12
    Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998; 18: 63536364.
  • 13
    Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 2000; 278: G173G183.
  • 14
    Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002; 110: 193202.
  • 15
    LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 32473259.
  • 16
    Webber EM, Bruix J, Pierce RH, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. HEPATOLOGY 1998; 28: 12261234.
  • 17
    Elsharkawy AM, Wright MC, Hay RT, Arthur MJ, Hughes T, Bahr MJ, et al. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. HEPATOLOGY 1999; 30: 761769.
  • 18
    Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003; 304: 463470.
  • 19
    Beljaars L, Meijer DK, Poelstra K. Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis. Front Biosci 2002; 7: e214e222.
  • 20
    Marek CJ, Cameron GA, Elrick LJ, Hawksworth GM, Wright MC. Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem J 2003; 370: 763769.
  • 21
    Wright MC, Paine AJ. Evidence that the loss of rat liver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and/or the absence of an extracellular matrix. Biochem Pharmacol 1992; 43: 237243.
  • 22
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.
  • 23
    Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 1980; 106: 5562.
  • 24
    Waring P, Newcombe N, Edel M, Lin QH, Jiang H, Sjaarda A, et al. Cellular uptake and release of the immunomodulating fungal toxin gliotoxin. Toxicon 1994; 32: 491504.
  • 25
    Qu B, Li QT, Wong KP, Tan TM, Halliwell B. Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radic Biol Med 2001; 31: 659669.
  • 26
    Harvey JL, Paine AJ, Maurel P, Wright MC. Effect of the adrenal 11-beta-hydroxylase inhibitor metyrapone on human hepatic cytochrome P-450 expression: induction of cytochrome P-450 3A4. Drug Metab Dispos 2000; 28: 96101.
  • 27
    Woodfield K, Ruck A, Brdiczka D, Halestrap AP. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 1998; 336: 287290.
  • 28
    Babson JR, Gavitt NE, Dougherty JM. Chlorpromazine protection against Ca(2+)-dependent and oxidative cell injury. Limitations due to depressed mitochondrial function. Biochem Pharmacol 1994; 48: 15091517.
  • 29
    Ding WX, Shen HM, Ong CN. Pivotal role of mitochondrial Ca2+ in microcystin-induced mitochondrial permeability transition in rat hepatocytes. Biochem Biophys Res Commun 2001; 285: 11551161.
  • 30
    Ding WX, Shen HM, Ong CN. Critical role of reactive oxygen species and mitochondrial permeability transition in microcystin-induced rapid apoptosis in rat hepatocytes. HEPATOLOGY 2000; 32: 547555.
  • 31
    Sorrentino D, Van Ness K, Ribeiro I, Miller CM. Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. HEPATOLOGY 1991; 14: 331339.
  • 32
    Bratton SB, Cohen GM. Apoptotic death sensor: an organelle's alter ego? Trends Pharmacol Sci 2001; 22: 306315.
  • 33
    Rodriguez-Ariza A, Paine AJ. Rapid induction of NF-kappaB binding during liver cell isolation and culture: inhibition by L-NAME indicates a role for nitric oxide synthase. Biochem Biophys Res Commun 1999; 257: 145148.
  • 34
    Bernardo PH, Chai CL, Deeble GJ, Liu XM, Waring P. Evidence for gliotoxin-glutathione conjugate adducts. Bioorg Med Chem Lett 2001; 11: 483485.
  • 35
    Hurne AM, Chai CL, Moerman K, Waring P. Influx of calcium through a redox-sensitive plasma membrane channel in thymocytes causes early necrotic cell death induced by the epipolythiodioxopiperazine toxins. J Biol Chem 2002; 277: 3163131638.
  • 36
    Hurne AM, Chai CL, Waring P. Inactivation of rabbit muscle creatine kinase by reversible formation of an internal disulfide bond induced by the fungal toxin gliotoxin. J Biol Chem 2000; 275: 2520225206.
  • 37
    Waring P, Beaver J. Gliotoxin and related epipolythiodioxopiperazines. Gen Pharmacol 1996; 27: 13111316.
  • 38
    Jakubowski W, Bartosz G. 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 2000; 24: 757760.
  • 39
    Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie 2002; 84: 153166.
  • 40
    Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341: 233249.
  • 41
    Majima E, Koike H, Hong YM, Shinohara Y, Terada H. Characterization of cysteine residues of mitochondrial ADP/ATP carrier with the SH-reagents eosin 5-maleimide and N-ethylmaleimide. J Biol Chem 1993; 268: 2218122187.
  • 42
    McStay GP, Clarke SJ, Halestrap AP. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 2002; 367: 541548.
  • 43
    Brennan P, O'Neill LA. 2-mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochem J 1996; 320: 975981.
  • 44
    Wild AC, Mulcahy RT. Pyrrolidine dithiocarbamate up-regulates the expression of the genes encoding the catalytic and regulatory subunits of gamma-glutamylcysteine synthetase and increases intracellular glutathione levels. Biochem J 1999; 338: 659665.
  • 45
    Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling. J Biol Chem 2001; 276: 1203512040.
  • 46
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. HEPATOLOGY 2002; 36: 14981508.
  • 47
    Pahl HL, Krauss B, Schulze-Osthoff K, Decker T, Traenckner EB, Vogt M, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183: 18291840.
  • 48
    Oakley F, Mann J, Ruddell RG, Pickford J, Weinmaster G, Mann DA. Basal expression of Ikappa B-alpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch 1. J Biol Chem 2003; 278: 2435924370.
  • 49
    Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003; 9: 575581.